# Forbion European Acquisition Corp. (FRBN) Source: https://www.quantisnow.com/company/FRBN Generated: 2026-11-15T17:14:05.560Z - Ticker: FRBN - Exchange: NASDAQ - Sector: Finance - Industry: Blank Checks - IPO year: 2022 - Website: https://forbion.com/en/feac/ ## About Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware. ## Latest FRBN news and filings - 2024-02-14 21:55 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-forbion-european-acquisition-corp-5264593) - 2024-02-14 11:00 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-forbion-european-acquisition-corp-5258758) - 2024-02-08 17:51 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-forbion-european-acquisition-corp-5240912) - 2024-01-19 18:01 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-forbion-european-acquisition-corp-5195961) - 2023-11-13 11:45 UTC [SEC Form 15-12G filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-forbion-european-acquisition-corp-5078339) - 2023-11-01 21:53 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Regulation FD Disclosure](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-termination-of-5052117) - 2023-11-01 16:20 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-forbion-european-acquisition-corp-5049770) - 2023-10-31 23:05 UTC [SEC Form 4] [Forbion Growth Sponsor Feac I B.V. returned 3,373,496 units of Class A Ordinary Shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/forbion-growth-sponsor-feac-i-bv-returned-3373496-units-of-5048100) - 2023-10-31 22:59 UTC [SEC Form 4] [Forbion Growth Sponsor Feac I B.V. converted options into 1,373,496 units of Class A Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/forbion-growth-sponsor-feac-i-bv-converted-options-into-1373496-5048097) - 2023-10-31 22:12 UTC [SEC Form 3] [New insider Forbion Growth Sponsor Feac I B.V. claimed ownership of 2,000,000 units of Class A Ordinary Shares (SEC Form 3) (Amendment)](https://www.quantisnow.com/insight/new-insider-forbion-growth-sponsor-feac-i-bv-claimed-ownership-5048063) - 2023-10-31 21:07 UTC [SEC Form 25-NSE filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-forbion-european-acquisition-corp-5047904) - 2023-10-30 17:55 UTC [Market Insight] [Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-on-semiconductor-shares-are-trading-lower-by-around-18-5043848) - 2023-10-28 00:37 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-forbion-european-acquisition-corp-5042536) - 2023-10-25 17:49 UTC [Market Insight] [Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-owens-corning-shares-are-trading-lower-by-around-9-5037479) - 2023-10-24 21:10 UTC [SEC Form 8-K] [SEC Form 8-K filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-forbion-european-acquisition-corp-5035820) - 2023-10-17 20:58 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-forbion-european-acquisition-corp-5024699) - 2023-10-10 15:15 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-forbion-european-acquisition-corp-5012385) - 2023-10-06 18:02 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-forbion-european-acquisition-corp-5009059) - 2023-09-29 23:04 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-forbion-european-acquisition-corp-4995827) - 2023-09-15 16:02 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-regulation-fd-4973107) - 2023-09-13 21:08 UTC [SEC Form 425] [SEC Form 425 filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-forbion-european-acquisition-corp-4969658) - 2023-09-13 21:05 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-creation-of-4969643) - 2023-09-07 11:00 UTC [Leadership Update] [enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer](https://www.quantisnow.com/insight/engene-appoints-richard-bryce-mbchb-mrcgp-mfpm-as-chief-medical-4957958) - 2023-08-12 00:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-forbion-european-acquisition-corp-4887678) - 2023-07-28 14:40 UTC [SEC Form 425] [SEC Form 425 filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-forbion-european-acquisition-corp-4811145) - 2023-07-28 14:36 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-other-events-4811105) - 2023-06-06 21:23 UTC [SEC Form 425] [SEC Form 425 filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-forbion-european-acquisition-corp-4610679) - 2023-06-06 21:19 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-creation-of-4610651) - 2023-05-22 21:21 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-forbion-european-acquisition-corp-4541377) - 2023-05-22 21:16 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Regulation FD Disclosure (Amendment)](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-entry-into-4541317) - 2023-05-17 11:25 UTC [Market Insight] [Forbion European Acq CL A OR Shares To Resume Trade At 7:30 AM ET](https://www.quantisnow.com/insight/forbion-european-acq-cl-a-or-shares-to-resume-trade-4517588) - 2023-05-17 11:22 UTC [Market Chatter] [enGene, Inc. and Forbion European Acquisition Corp Reach A SPAC Merger Deal To Form A Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies](https://www.quantisnow.com/insight/engene-inc-and-forbion-european-acquisition-corp-reach-a-spac-4517578) - 2023-05-17 11:17 UTC [SEC Form 425] [SEC Form 425 filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-forbion-european-acquisition-corp-4517566) - 2023-05-17 11:13 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-entry-into-4517549) - 2023-05-17 11:00 UTC [enGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies](https://www.quantisnow.com/insight/engene-inc-and-forbion-european-acquisition-corp-feac-nasdaq-frbn-4517473) - 2023-05-12 19:23 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-forbion-european-acquisition-corp-4496050) - 2023-03-30 19:32 UTC [SEC Form 10-K] [SEC Form 10-K filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-forbion-european-acquisition-corp-4273598) - 2023-03-24 17:19 UTC [SEC Form 8-K] [Forbion European Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/forbion-european-acquisition-corp-filed-sec-form-8-k-creation-of-4246367) - 2023-02-14 13:02 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-forbion-european-acquisition-corp-4055076) - 2023-02-02 15:17 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Forbion European Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-forbion-european-acquisition-corp-3994041) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FRBN - Earnings history: https://www.quantisnow.com/earnings/FRBN - Dividend history: https://www.quantisnow.com/dividends/FRBN - Insider transactions: https://www.quantisnow.com/insiders/FRBN - Options chain: https://www.quantisnow.com/options/FRBN - SEC 8-K filings only: https://www.quantisnow.com/company/FRBN/8-k - RSS and alerts for FRBN: https://www.quantisnow.com/docs/rss-feeds.md